Aiming Pang

机构：Tianjin University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0003-3706-3139

发表论文 203 篇 · 总被引 1315 次 · h-index 17

代表论文

• Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants (2025 · Nature Communications · 被引 7)
• Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation (2025 · American Journal of Hematology · 被引 6)
• Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study (2025 · European Journal of Clinical Microbiology & Infectious Diseases · 被引 3)
• Efficacy of the triplet therapy with venetoclax, azacitidine and gilteritinib for the treatment of FLT3-ITD mutated AML patients with refractory/relapsed disease or persistent minimal residual disease bridging to allogeneic hematopoietic stem cell transplantation (2025 · Blood · 被引 2)
• FLT3-ITD with NPM1 and/or DNMT3A co-mutations in acute myeloid leukemia: prognostic significance and the role of maintenance therapy post-transplantation (2025 · Blood Science · 被引 1)
• Amphotericin B Colloidal Dispersion Is Effective and Safe for the Treatment of Invasive Aspergillosis in Chinese Patients with Hematologic Disease: A Multicenter, Prospective, Observational, Real-World Study (2026 · Drug Design Development and Therapy)